載入...
Rituximab in refractory sarcoidosis: a single centre experience
Sarcoidosis is a granulomatous disease whose outcome varies from spontaneous remission to chronic refractory disease. Provided that steroids represent the gold standard as a first line treatment, many immune suppressants drugs are currently used in the disease management. However, refractory disease...
Na minha lista:
| 發表在: | Clin Mol Allergy |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4556310/ https://ncbi.nlm.nih.gov/pubmed/26330764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12948-015-0025-9 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|